Citation Impact

Citing Papers

Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells
2006
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Innate Gender-based Proclivity in Response to Cytotoxicity and Programmed Cell Death Pathway
2004
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
2000 Standout
Estrogen receptors and human disease
2006 Standout
Myasthenia Gravis
2016 Standout
Psoriasis
2009 Standout
Efforts to Prevent and Halt Autoimmune Beta Cell Destruction
2010
Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis
2013
Autoimmune Diseases
2001
New frontiers in nanotechnology for cancer treatment
2008
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Mechanisms and consequences of fibrosis in systemic sclerosis
2006
Biodegradable luminescent porous silicon nanoparticles for in vivo applications
2009 Standout
Cancer immunotherapy: breaking the barriers to harvest the crop
2004 StandoutNobel
Mesenchymal stem cells in health and disease
2008 Standout
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
2009
Systemic sclerosis
2017 Standout
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis
2017
The PufferfishSLP-1Gene, a New Member of theSCL/TAL-1Family of Transcription Factors
1998
Central nervous system complications in liver transplant recipients – incidence, timing, and long‐term follow‐up
2000
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia
2005
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
2008 Standout
Celiac Disease
2007 Standout
Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategies
2005
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Aspergillosis
2002
Adult stem cells in the treatment of autoimmune diseases
2006
Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission – experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)
2004
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Graft-versus-host disease
2009 Standout
Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain
2020 StandoutNobel
Antifungal prophylaxis for severely neutropenic chemotherapy recipients
2002
Photodynamic therapy and anti-tumour immunity
2006 Standout
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Pregnancy outcome in hematologic malignancies
1991
Type 1 diabetes
2013 Standout
Sickle-cell disease
2010 Standout
Application of Nanotechnology in Cancer Therapy and Imaging
2008
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics
2001
Microenvironmental regulation of metastasis
2008 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause
2007 Standout
Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy
2008
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production
2008 Standout
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Non‐comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation
2006
A review of autologous hematopoietic cell transplantation
2000 Nobel
A Personal History of the CAMPATH-1H Antibody
2002
Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial
2011
Towards a targeted, risk‐based, antifungal strategy in neutropenic patients
2000
Preservation of Fertility in Patients with Cancer
2009 Standout
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Multiple sclerosis
2002 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
High-Resolution Description of Antibody Heavy-Chain Repertoires in Humans
2011
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal Antibody (Rituximab, IDEC-C2B8)
1999
Dr William Coley and tumour regression: a place in history or in the future
2003
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Antitumor Antibiotics:  Bleomycin, Enediynes, and Mitomycin
2005 Standout
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies
2003
Late changes in spliceosomal introns define clades in vertebrate evolution
1999 StandoutNobel
Policy: NIH to balance sex in cell and animal studies
2014 StandoutNature
Cell Surface Antigen and Molecular Targeting in the Treatment of Hematologic Malignancies
2002
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Hormone Replacement Therapy and Stroke
2004
Multiple Sclerosis
2018 Standout
Combination Antifungal Therapy
2004
Intravenous and Oral Itraconazole versus Intravenous and Oral Fluconazole for Long-Term Antifungal Prophylaxis in Allogeneic Hematopoietic Stem-Cell Transplant Recipients: A Multicenter, Randomized Trial
2003
Microglia: Scapegoat, Saboteur, or Something Else?
2013 Science
AspergillusInfections in Transplant Recipients
2005
Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants
2003
Postischemic Estrogen Reduces Hypoperfusion and Secondary Ischemia After Experimental Stroke
2001
Cytokine Storm
2020 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Estrogen receptor alpha , not beta , is a critical link in estradiol-mediated protection against brain injury
2001
The Potential of Mesenchymal Stromal Cells as a Novel Cellular Therapy for Multiple Sclerosis
2012
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
2003 Standout
Clinical and Histopathological Features of Patients with Systemic Sclerosis Undergoing Endomyocardial Biopsy
2015
Monoclonal Antibody Therapy of B Cell Lymphoma: Signaling Activity on Tumor Cells Appears More Important Than Recruitment of Effectors
1998
Customizing the genome as therapy for the β-hemoglobinopathies
2016
Alemtuzumab for patients with chronic lymphocytic leukaemia
2012
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients1
2002
Itraconazole Prevents Invasive Fungal Infections in Neutropenic Patients Treated for Hematologic Malignancies: Evidence From a Meta-Analysis of 3,597 Patients
2003
Antifungal Prophylaxis in Cancer Patients After Chemotherapy or Hematopoietic Stem-Cell Transplantation: Systematic Review and Meta-Analysis
2007
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device
2021 StandoutNobel
Itraconazole Preexposure Attenuates the Efficacy of Subsequent Amphotericin B Therapy in a Murine Model of Acute Invasive Pulmonary Aspergillosis
2002
Estradiol Regulates Angiopoietin-1 mRNA Expression Through Estrogen Receptor-α in a Rodent Experimental Stroke Model
2005
Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation
2016
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
Effects of Conjugated Equine Estrogen on Stroke in the Women’s Health Initiative
2006

Works of Αthanasios Fassas being referenced

Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases
2009
Humanized CD52 monoclonal antibody campath‐1H as first‐line treatment in chronic lymphocytic leukaemia
1996
Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe β-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects
2011
Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation
2000
Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study
1997
Collection of hematopoietic stem cells from patients with autoimmune diseases
2001
The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia
2005
ANTICARDIOLIPIN ANTIBODY-ASSOCIATED STROKE AFTER LIVER TRANSPLANTATION
1997
Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis
2005
Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis
2004
Autologous Stem Cell Transplantation in Progressive Multiple Sclerosis—An Interim Analysis of Efficacy
2000
Immunoglobulin genes in multiple myeloma: expressed and non-expressed repertoires, heavy and light chain pairings and somatic mutation patterns in a series of 101 cases.
2006
Safety and early efficacy assessment of liposomal daunorubicin (DaunoXome) in adults with refractory or relapsed acute myeloblastic leukaemia: a phase I–II study
2002
Long-term results of stem cell transplantation for MS
2011
Itraconazole Oral Solution for Primary Prophylaxis of Fungal Infections in Patients with Hematological Malignancy and Profound Neutropenia: a Randomized, Double-Blind, Double-Placebo, Multicenter Trial Comparing Itraconazole and Amphotericin B
2000
Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome
2007
Spontaneous remission of acute myeloid leukemia in a patient with concurrent Pneumocystis carinii pneumonia.
1991
Chemotherapy for acute leukemia during pregnancy. Five case reports.
1984
Rankless by CCL
2026